good post. If the valuation is correct, then the stock price of gnbt should continue to go up with the valuable asset that it owns. Prior to the spinoff of ngio the price of gnbt should closer to $5.
I assume that the value of gnbt needs to be at least $4 in order to be listed on the nasdaq. So if they decide to issue 100 million to 125 million shares we should be somewhere between $4 and $5 share for ngio, and at least that range for gnbt not taking into account the other businesses they own.
Generex Biotechnology Corp. (GNBT) Stock Research Links